Showing results (61-70 of 2,029) with videos related to
Sort By:
Pageof 203
Clinical Science (London, England : 1979)|December 1, 1980
Sodium-potassium-dependent ATPase activity in erythrocyte ghosts of patients with primary and secondary hypertensionG Wambach, A Helber, G Bönner, et al.Clinical Science (London, England : 1979)|October 1, 1982
Renal kallikrein activity and urinary kallikrein excretion in rats with experimental renal hypertensionM Marin-Grez, G Schaechtelin, G Bönner, et al.Deutsche Medizinische Wochenschrift (1946)|June 18, 1982
[Primary hyperaldosteronism: differentiation between aldosterone-producing adenoma and idiopathic adrenocortical hyperplasia (author's transl)]G Wambach, A Helber, G Bönner, et al.Deutsche Medizinische Wochenschrift (1946)|March 23, 1979
[The saralasin test in the diagnosis of hypertension (author's transl)]G Bönner, A Helber, K A Meurer, et al.Agents and Actions. Supplements|January 1, 1992
Lack of oral kallikrein in lowering systemic blood pressure in primary hypertensionG Bönner, C Toussaint, M Claus, et al.Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|December 1, 1985
Haemorheology in adolescent hypertensivesV Hossmann, H Auel, G Bönner, et al.Klinische Wochenschrift|January 1, 1978
Pharmacokinetic and pharmacodynamic studies of infusions with [Sar 1, Val5, Ala8] angiotensin II (saralasin)K H Gless, G Bönner, N Gram, et al.Fundamental & Clinical Pharmacology|February 19, 2000
Comparison of the efficacy and safety of losartan (50-100 mg) with the T-type calcium channel blocker mibefradil (50-100 mg) in mild to moderate hypertensionO Chung, M Hinder, A M Sharma, et al.Clinical Science (London, England : 1979)|December 1, 1979
A novel orally active converting-enzyme inhibitor YS 980: effects on blood pressure in spontaneously hypertensive ratsT Unger, R W Rockhold, K Schaz, et al.Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1982
Characterization of a group of essential hypertensives with impaired regulation of aldosteroneG Wambach, A Helber, G Bönner, et al.Pageof 203